BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 25960241)

  • 1. The effects of HAART on the expression of MUC1 and P65 in a cervical cancer cell line, HCS-2.
    Thabethe KR; Adefolaju GA; Hosie MJ
    Biomed Pharmacother; 2015 Apr; 71():227-32. PubMed ID: 25960241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of AMPKα mediates additive effects of solamargine and metformin on suppressing MUC1 expression in castration-resistant prostate cancer cells.
    Xiang S; Zhang Q; Tang Q; Zheng F; Wu J; Yang L; Hann SS
    Sci Rep; 2016 Nov; 6():36721. PubMed ID: 27830724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of HIV protease, nucleoside/non-nucleoside reverse transcriptase inhibitors on Bax, Bcl-2 and apoptosis in two cervical cell lines.
    Adefolaju GA; Theron KE; Hosie MJ
    Biomed Pharmacother; 2014 Mar; 68(2):241-51. PubMed ID: 24011602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AIDS malignancies in the era of highly active antiretroviral therapy.
    Gates AE; Kaplan LD
    Oncology (Williston Park); 2002 May; 16(5):657-65; discussion 665, 668-70. PubMed ID: 12108891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Highly Active AntiRetroviral Therapy and opportunistic protozoan infections].
    Pozio E
    Parassitologia; 2004 Jun; 46(1-2):89-93. PubMed ID: 15305694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MUC1 promotes cervical squamous cell carcinoma through ERK phosphorylation-mediated regulation of ITGA2/ITGA3.
    Zhao A; Pan Y; Gao Y; Zhi Z; Lu H; Dong B; Zhang X; Wu M; Zhu F; Zhou S; Ma S
    BMC Cancer; 2024 May; 24(1):559. PubMed ID: 38702644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose radiation-induced epithelial-mesenchymal transition through NF-κB in cervical cancer cells.
    Yan S; Wang Y; Yang Q; Li X; Kong X; Zhang N; Yuan C; Yang N; Kong B
    Int J Oncol; 2013 May; 42(5):1801-6. PubMed ID: 23483258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HAART induces cell death in a cervical cancer cell line, HCS-2: A Scanning Electron Microscopy study.
    Xulu KR; Hosie MJ
    J Microsc Ultrastruct; 2017; 5(1):39-48. PubMed ID: 30023236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel MUC1 splice variants are expressed in cervical carcinoma.
    Obermair A; Schmid BC; Stimpfl M; Fasching B; Preyer O; Leodolter S; Crandon AJ; Zeillinger R
    Gynecol Oncol; 2001 Nov; 83(2):343-7. PubMed ID: 11606095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [AIDS associated cancers in the era of highly active antiretroviral therapy (HAART)].
    Tserenpuntsag B; Kołacińska A; Jabłonowska E
    Przegl Epidemiol; 2007; 61(3):529-34. PubMed ID: 18069390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor necrosis factor alpha stimulates MUC1 synthesis and ectodomain release in a human uterine epithelial cell line.
    Thathiah A; Brayman M; Dharmaraj N; Julian JJ; Lagow EL; Carson DD
    Endocrinology; 2004 Sep; 145(9):4192-203. PubMed ID: 15142990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Limited impact of immunosuppression and HAART on the incidence of cervical squamous intraepithelial lesions in HIV-positive women.
    Heard I; Potard V; Costagliola D
    Antivir Ther; 2006; 11(8):1091-6. PubMed ID: 17302379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of antiretroviral therapy on the incidence of cervical neoplasia among HIV-infected women: a population-based cohort study in Taiwan.
    Chen YC; Li CY; Liu HY; Lee NY; Ko WC; Ko NY
    AIDS; 2014 Mar; 28(5):709-15. PubMed ID: 24326354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MUC1* is a determinant of trastuzumab (Herceptin) resistance in breast cancer cells.
    Fessler SP; Wotkowicz MT; Mahanta SK; Bamdad C
    Breast Cancer Res Treat; 2009 Nov; 118(1):113-24. PubMed ID: 19415485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of highly active antiretroviral therapy on the incidence and outcomes of AIDS-defining cancers in Southern Alberta.
    Gingues S; Gill MJ
    HIV Med; 2006 Sep; 7(6):369-77. PubMed ID: 16903981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential impact of antiretroviral therapy and screening on cervical cancer mortality in HIV-positive women in sub-Saharan Africa: a simulation.
    Atashili J; Smith JS; Adimora AA; Eron J; Miller WC; Myers E
    PLoS One; 2011 Apr; 6(4):e18527. PubMed ID: 21483701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Highly active antiretroviral therapy and cervical squamous intraepithelial lesions in human immunodeficiency virus-positive women.
    Ahdieh-Grant L; Li R; Levine AM; Massad LS; Strickler HD; Minkoff H; Moxley M; Palefsky J; Sacks H; Burk RD; Gange SJ
    J Natl Cancer Inst; 2004 Jul; 96(14):1070-6. PubMed ID: 15265968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of KL-6/MUC1 in pancreatic cancer tissues and its potential involvement in tumor metastasis.
    Xu H; Inagaki Y; Seyama Y; Du G; Wang F; Kokudo N; Tang W
    Oncol Rep; 2011 Aug; 26(2):371-6. PubMed ID: 21617869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucin 1 enhances the tumor angiogenic response by activation of the AKT signaling pathway.
    Woo JK; Choi Y; Oh SH; Jeong JH; Choi DH; Seo HS; Kim CW
    Oncogene; 2012 Apr; 31(17):2187-98. PubMed ID: 21927028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.